Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COURAGE
2024-515308-38-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute urticaria comparing Prednisone with Placebo (2 arms). Primary endpoint: 7-Day Urticaria Activity Score at day 7. Started Aug 2024; status: completed.
02
Drugs
prednisone
03
Conditions
acute urticaria
Beyond the preview
Go deeper on 2024-515308-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515308-38-00.